Centene Corporation Underwriting AgreementCentene Corp • November 7th, 2012 • Hospital & medical service plans • New York
Centene Corporation, a Delaware corporation (the “Company”), proposes to issue and sell $175,000,000 aggregate principal amount of its 5.75% Senior Notes due 2017 (the “Notes”) to the several underwriters named on Schedule I hereto (the “Underwriters”), for which Barclays Capital Inc. and Wells Fargo Securities, LLC are acting as representatives (the “Representatives”). The Notes will be issued pursuant to the indenture (the “Indenture”), dated as of May 27, 2011, between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”). The Company previously issued $250,000,000 aggregate principal amount of the Company’s 5.75% Senior Notes due 2017 (the “Existing Notes”) under the Indenture. The Notes constitute an offering of “Additional Notes” (as such term is defined in the Indenture) under the Indenture. Except as disclosed in the Disclosure Package as of the Applicable Time and the Prospectus dated as of the date hereof (each as defined in Section 1(a)
AMENDMENT NO. 1 TO CREDIT AGREEMENTCredit Agreement • November 7th, 2012 • Centene Corp • Hospital & medical service plans • New York
This AMENDMENT NO. 1 dated as of November 2, 2012 (this “Amendment”) to the Credit Agreement dated as of January 31, 2011 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”) is entered into among CENTENE CORPORATION (the “Company”), the financial institutions from time to time party thereto (the “Lenders”) and BARCLAYS BANK PLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).
